The mission of Spectrum, the CTSA-supported independent research center at Stanford, is to transform the academic enterprise to optimally support clinical and translational research and education (CTRE). Spectrum's programs are designed to extend from the earliest phase of basic discovery to final implementation of these discoveries in the population. The ultimate goals of our efforts are to streamline the translation of basic innovations into practical solutions that maintain and improve human health, and to educate the next generation of CTR leaders. In the next five years. Spectrum will leverage institutional strengths to nurture our entrepreneurial researchers to efficiently transfer discoveries from the laboratory to the bedside and into the community. The CTSA will provide critical resources, services and educational opportunities to ensure progress toward this mission.
The specific aims of Spectrum are: 1) Educate the next generation of investigators with the multidisciplinary skills required to conduct cutting- edge clinical and translational research to meet the opportunities and challenges of medicine in the 21st century. Spectrum will facilitate the transformation of medical research training from a narrow focus on discipline-restricted expertise to a more interdisciplinary team approach where trainees become conversant in the language, processes and tools used across the full extent of the translational pipeline (T1-T4). 2) Create an institutional home conducive to efficiently translating the most innovative discoveries made by our basic, translational and clinical scientists into products and processes that directly improve human health and well-being. Spectrum will provide the institutional environment to identify and then support those discoveries that are most ready for translation. 3) Develop and implement CTRE resources and services to accelerate the translation of discoveries into better human health, while simultaneously reducing operating costs. Spectrum will ensure that investigators receive the necessary clinical trial, informatics, statistics, regulatory, ethics and administrative support to maximize their research productivity, and optimize the participation of diverse populations.

Public Health Relevance

The mission of Spectrum, Stanford's CTSA-supported center, is to transform the enterprise to best support discovery, innovation and education in clinical and translational research across the university. Spectrum's programs extend from the earliest phase of basic discovery to final implementation in the population, with an ultimate goal of strengthening healthcare and improving cost efficiencies.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
3UL1TR001085-04S1
Application #
9252877
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Wilson, Todd
Project Start
2013-09-26
Project End
2018-04-30
Budget Start
2016-08-01
Budget End
2017-04-30
Support Year
4
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94304
Ho, Annabell; Hancock, Jeff; Miner, Adam S (2018) Psychological, Relational, and Emotional Effects of Self-Disclosure After Conversations With a Chatbot. J Commun 68:712-733
Burgener, Elizabeth B; Moss, Richard B (2018) Cystic fibrosis transmembrane conductance regulator modulators: precision medicine in cystic fibrosis. Curr Opin Pediatr 30:372-377
Forlenza, Gregory P; Raghinaru, Dan; Cameron, Faye et al. (2018) Predictive hyperglycemia and hypoglycemia minimization: In-home double-blind randomized controlled evaluation in children and young adolescents. Pediatr Diabetes 19:420-428
Girsen, Anna I; Mayo, Jonathan A; Wallenstein, Matthew B et al. (2018) What factors are related to recurrent preterm birth among underweight women? J Matern Fetal Neonatal Med 31:560-566
Pu, Szu-Yuan; Wouters, Randy; Schor, Stanford et al. (2018) Optimization of Isothiazolo[4,3- b]pyridine-Based Inhibitors of Cyclin G Associated Kinase (GAK) with Broad-Spectrum Antiviral Activity. J Med Chem :
Mello, Michelle M; Lieou, Van; Goodman, Steven N (2018) Clinical Trial Participants' Views of the Risks and Benefits of Data Sharing. N Engl J Med 378:2202-2211
Yu, Jessica X; Oliver, Melissa; Lin, Jody et al. (2018) Patients Prescribed Direct-acting Oral Anticoagulants Have Low Risk of Post-Polypectomy Complications. Clin Gastroenterol Hepatol :
Williams, Nolan R; Bentzley, Brandon S; Hopkins, Thomas et al. (2018) Optimization of epidural cortical stimulation for treatment-resistant depression. Brain Stimul 11:239-240
Ehrenkaufer, Gretchen M; Suresh, Susmitha; Solow-Cordero, David et al. (2018) High-Throughput Screening of Entamoeba Identifies Compounds Which Target Both Life Cycle Stages and Which Are Effective Against Metronidazole Resistant Parasites. Front Cell Infect Microbiol 8:276
Aggarwal, Abhishek; Feldman, David; Feldman, Brian J (2018) Identification of tumor-autonomous and indirect effects of vitamin D action that inhibit breast cancer growth and tumor progression. J Steroid Biochem Mol Biol 177:155-158

Showing the most recent 10 out of 406 publications